Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis

Pediatr Blood Cancer. 2021 Jan;68(1):e28576. doi: 10.1002/pbc.28576. Epub 2020 Sep 8.

¹ Pediatric Oncology Department, University Hospital, Angers, France.
² Obstetrics and Fetal Medicine Department, Hôpital Necker-Enfants Malades, APHP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
³ Pathology Department, Hôpital Necker-Enfants Malades, APHP, Paris, France.
⁴ Intensive Care Unit, Hôpital Necker-Enfants Malades, APHP, Paris, France.
⁵ Pediatric Department, Hospital Center, Le Mans, France.
⁶ Department of Somatic Genetic, Institut Curie, Paris, France.
⁷ Reference Centre for Genodermatoses and Rare Skin Disease (MAGEC), Hôpital Necker-Enfants Malades, APHP, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
⁸ SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France.

No abstract available

Publication types